DOCSLIB.ORG

Medmen Enterprises, Inc. Form S-1 Filed 2021-03-08

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medmen Enterprises, Inc. Form S-1 Filed 2021-03-08 SECURITIES AND EXCHANGE COMMISSION FORM S-1 General form of registration statement for all companies including face-amount certificate companies Filing Date: 2021-03-08 SEC Accession No. 0001477932-21-001299 (HTML Version on secdatabase.com) FILER MedMen Enterprises, Inc. Mailing Address Business Address 10115 JEFFERSON 10115 JEFFERSON CIK:1776932| IRS No.: 981431779 | State of Incorp.:A1 | Fiscal Year End: 0630 BOULEVARD BOULEVARD Type: S-1 | Act: 33 | File No.: 333-253980 | Film No.: 21721362 CULVER CITY CA 90232 CULVER CITY CA 90232 SIC: 5990 Retail stores, nec 4243302082 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document As filed with the Securities and Exchange Commission on March 8, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDMEN ENTERPRISES INC. (Exact name of registrant as specified in its charter) British Columbia 5912 98-1431779 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 10115 Jefferson Boulevard Culver City, CA 90232 (424) 330-2082 (Address and telephone number of registrant’s principal executive offices) Reece Fulgham Chief Financial Officer 10115 Jefferson Boulevard Culver City, CA 90232 (424) 330-2082 (Name, Address and Telephone Number of Agent for Service) Copy to: Thomas J. Poletti, Esq. Katherine J. Blair, Esq. Manatt, Phelps & Phillips, LLP 695 Town Center Drive, 14th Floor Costa Mesa, CA 92646 (714) 312-7500 (Approximate date of commencement of proposed sale to the public) As soon as practicable after the effective date of this Registration Statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒ CALCULATION OF REGISTRATION FEE Proposed Proposed Maximum Maximum Offering Aggregate Amount of Amount to be Price per Offering Registration Title of Securities to be Registered Registered (1) Share Price Fee Class B Subordinate Voting Shares (2) 37,383,208 $ 0.35(3) $ 13,016,231.32 $ 1,420.07 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Class B Subordinate Voting Shares issuable upon exercise of warrants 174,595,005 $ 0.25(4) $ 43,648,751.25 $ 4,762.08 Class B Subordinate Voting Shares issuable upon conversion of convertible notes 32,132,350 $ 0.20(5) $ 6,426,470.07 $ 701.13 Total $ 6,883,28 (1) This Registration Statement includes an indeterminate number of additional Class B Subordinate Voting Shares issuable for no additional consideration pursuant to any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration, which results in an increase in the number of Class B Subordinate Voting Shares. In the event of a stock split, stock dividend or similar transaction involving our Common Stock, in order to prevent dilution, the number of shares registered shall be automatically increased to cover the additional shares in accordance with Rule 416(b) under the Securities Act of 1933, as amended (the “Securities Act”). (2) Represents Class B Subordinate Voting Shares registered for resale by the selling shareholders named in this prospectus. (3) Estimated in accordance with Rule 457(c) and (h) under the Securities Act, solely for the purpose of calculating the registration fee on the basis of an assumed price of $0.35 per share, which is the average of the high (C$0.51) and low (C$0.44) prices of the Registrant’s Class B Subordinate Voting Shares in Canadian dollars (“C$”) as reported on the Canadian Securities Exchange on March 4, 2021, which date is within five business days prior to filing this registration statement, and as converted from Canadian dollars to United States dollars based on the foreign exchange rate (1.2637) as published by the Bank of Canada on March 4, 2021. (4) In accordance with Rule 457(g) of the Securities Act, based upon the weighted average exercise price per share of Class B Subordinate Voting Shares issuable upon exercise of warrants. (5) In accordance with Rule 457(g) of the Securities Act, based upon the weighted average conversion price per share of Class B Subordinate Voting Shares issuable upon conversion of convertible notes. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine. The information contained in this prospectus is not complete and may be changed. The selling stockholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and the selling stockholders are not soliciting offers to buy these securities in any state where the offer or sale of these securities is not permitted. SUBJECT TO COMPLETION, DATED March 5, 2021 PRELIMINARY PROSPECTUS MEDMEN ENTERPRISES INC. 244,110,563 Class B Subordinate Voting Shares This prospectus relates the offer and sale or other disposition from time to time of up to an aggregate of 244,110,563 Class B Subordinate Voting Shares (the “Subordinate Voting Shares”) of MedMen Enterprises Inc. by the selling shareholders named in this prospectus, (together with their respective donees, transferees or other successors in interest, referred to as the “selling shareholders”), which consists of 37,383,208 Subordinate Voting Shares, 174,595,005 Subordinate Voting Shares issuable upon exercise of warrants, and 32,132,350 Subordinate Voting Shares issuable upon conversion of convertible notes (the “Resale Shares”). Registration of the Resale Shares does not mean that the selling shareholders will actually offer or sell any of these shares. We will not receive any proceeds from the sale or other disposition of the Resale Shares offered by the selling shareholders. We will, however, receive the exercise price of any warrants exercised for cash. To the extent that we receive cash upon exercise of any warrants, we expect to use that cash for working capital and general corporate purposes. The selling shareholders or their transferees may, from time to time, sell, transfer or otherwise dispose of any or all of their Subordinate Voting Shares or interests in Subordinate Voting Shares on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. For additional information, you should refer to the section entitled “Plan of Distribution” of this prospectus. We are paying all expenses of registration incurred in connection with this offering, except any underwriting discounts and commissions incurred by the selling stockholders. Our Subordinate Voting Shares trade on the Canadian Securities Exchange (“CSE”) under the symbol “MMEN”. The closing sales price of our Subordinate Voting Shares on the CSE on March 4, 2021 was C$0.46 per share. Our Subordinate Voting Shares also trade on the OTCQX under the symbol “MMNFF.” The last reported sales price of our Subordinate Voting Shares on the OTCQX on March 4, 2021 was $0.37 per share. We are an “emerging growth company”, as defined under the federal securities laws and, as such, we may continue to elect to comply with certain reduced public company reporting requirements in future reports. Certain implications of being an “emerging growth company” are described on page 3 of this prospectus. Investing in our Subordinate Voting Shares involves a high degree of risk. You should refer to the discussion of risk factors, beginning on page 10 of this prospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Load more

Recommended publications
  • Medmen Enterprises Inc. Management's Discussion
    MEDMEN ENTERPRISES INC. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018 MEDMEN ENTERPRISES INC. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018 This management discussion and analysis (“MD&A”) of the financial condition and results of operations of MedMen Enterprises Inc. (“MedMen Enterprises”, “MedMen” or the “Company”), formerly known as The MedMen Group of Companies, is for the three months ended September 30, 2018. It is supplemental to, and should be read in conjunction with, the Annual Information Form filed on November 5, 2018 on Sedar.com, the Company’s unaudited interim condensed consolidated interim financial statements and the accompanying notes for the three months ended September 30, 2018. The Company’s unaudited interim condensed consolidated financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). Financial information presented in this MD&A is presented in United States dollars (“$” or “US$”), unless otherwise indicated. This MD&A is presented as of November 29, 2018. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This MD&A includes “forward-looking information” and “forward-looking statements” within the meaning of Canadian securities laws and United States securities laws. All information, other than statements of historical facts, included in this MD&A that addresses activities, events or developments
    [Show full text]
  • The Need for Federal Regulation of Marijuana Marketing
    Opinion VIEWPOINT The Need for Federal Regulation of Marijuana Marketing John W. Ayers, PhD, A national for-profit marijuana industry is expanding The company’s blog Ember: A Journal of Cannabis and MA substantially in the United States. Thirty-three states Culture has an entire section dedicated to health, includ- Division of Infectious have legalized medical marijuana, 10 of which (where ing a claim that marijuana “can reduce anxiety,pain, and Diseases and Global 1 in 4 individuals reside) have also legalized recre- so much more,”3 a physician’s recommended list of mari- Public Health, 4 Department of ational marijuana. Sales of marijuana are projected to juana products for menstrual cramps, and promotion Medicine, University of increase from $8.5 billion to $75 billion by 2030, rival- of marijuana as a safe, natural, and nonaddictive alter- California San Diego, ing current tobacco sales ($125 billion).1 The initial native to prescription medications, even implying that La Jolla. marijuana marketplace was limited to a few states, but marijuana can treat opioid addiction, an opinion with emerging brands have developed sophisticated which experts disagree.5 The first national radio– Theodore Caputi, MPH national marketing campaigns that could potentially podcast advertisements in 2018 did not mention mari- Division of Infectious have an effect across state lines. This marketplace juana, but advertised unnamed wellness treatments. Diseases and Global expansion, along with questionable marketing prac- A planned collaboration with Gwyneth Paltrow’s Goop, Public Health, 6 Department of tices, introduces a need for federal action. which was recently fined for misleading health claims, Medicine, University of has been announced.
    [Show full text]
  • Offering Memorandum Pensacola, Florida
    Offering Memorandum Pensacola, Florida Subject Property 10-Year Lease with Approx. 3% Annual Rent Increases Outparcel to Cordova Mall, Local Economy is Driven by Eight Years Remaining on Throughout Base Term and the Largest Shopping Center Military, Defense Industry, Base Term Options on the NW Gulf Coast of FL Tourism & Healthcare CONFIDENTIALITY AND DISCLAIMER NET LEASED DISCLAIMER The information contained in the following Marketing Brochure is proprietary and Marcus & Millichap hereby advises all prospective purchasers of Net Leased property strictly confidential. It is intended to be reviewed only by the party receiving it from as follows: Marcus & Millichap Real Estate Investment Services of Florida, Inc. and should not be made available to any other person or entity without the written consent of Marcus & The information contained in this Marketing Brochure has been obtained from sources Millichap. This Marketing Brochure has been prepared to provide summary, unverified we believe to be reliable. However, Marcus & Millichap has not and will not verify any information to prospective purchasers, and to establish only a preliminary level of of this information, nor has Marcus & Millichap conducted any investigation regarding interest in the subject property. The information contained herein is not a substitute these matters. Marcus & Millichap makes no guarantee, warranty or representation for a thorough due diligence investigation. Marcus & Millichap has not made any whatsoever about the accuracy or completeness of any information provided. investigation, and makes no warranty or representation, with respect to the income or expenses for the subject property, the future projected financial performance of the As the Buyer of a net leased property, it is the Buyer’s responsibility to independently property, the size and square footage of the property and improvements, the presence confirm the accuracy and completeness of all material information before completing or absence of contaminating substances, PCB’s or asbestos, the compliance with any purchase.
    [Show full text]
  • How Adam Bierman Built Medmen Into an Influential Industry Player
    Creating a best-selling cannabis edible in a crowded market $12.95 VOL 4 • ISSUE 8 • September 2017 Crop storage+ strategies Vape industry overview Getting a grow NO off the ground APOLOGHow Adam Bierman built ¬ES MedMen into an influential industry player despite his blunt, controversial style 312.869.9070 IF YOU’RE NOT MESSAGING YOUR CUSTOMERS, THEN SOMEBODY ELSE IS! SMS is the best and most effective way to increase your daily store traffi c. Our clients say a blast brings in 10-50 incremental customers (per 1000 messaged). MESSAGING PAYS FOR ITSELF 10 TIMES OVER! A 420 sending number to increase Reliable delivery. No blocking. brand effectiveness. Excellent customer service. UP TO 240 CHARACTERS PER MESSAGE Need help building your opt in list? (50% more than others). More info to We got you covered. your customers means more sales. Great prices. Discounts for Picture messaging (MMS) available. higher volumes. No contracts or setup fees. 90% OF SMS ARE READ WITHIN 3 MINUTES OF RECEIPT. 4 20 YOU CAN’T AFFORD Thursday, April 20 NOT TO USE NORTHTEXT. Dispensary now SMS messaging expertise tailored specifi cally to the Dispensary market WWW.NORTHTEXT.COM/DISPENSARY | 312.869.9070 In business since 2007 Trim-8.375x10.875.qxp_Layout 1 1/20/17 10:22 AM Page 1 System 420™ Hybrid Greenhouses Larger Yields, Better Crops, Lower Costs PRODUCTION YIELDS With over 1 million square feet of Light deprivation, environmental controls, and benching systems Why Nexus? cannabis greenhouses constructed in provide the tools to optimize the 11 states, Nexus has developed unique expertise in designing grow system for high capacity integrated cannabis growing systems.
    [Show full text]
  • Medmen Awarded New Adult Use License in Morton Grove, Illinois
    NEWS RELEASE MedMen Awarded New Adult Use License in Morton Grove, Illinois 3/30/2021 Store expected to be signicant growth driver in MedMen’s portfolio of premier retail stores across the country LOS ANGELES--(BUSINESS WIRE)-- Coming o the success of MedMen’s Illinois locations in Evanston and Oak Park, MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), is pleased to announce it was awarded a new license to open an adult-use dispensary in Morton Grove, Illinois. The license was issued to MME Morton Grove Retail, LLC, a wholly owned subsidiary of MedMen, for the operation of an adult-use dispensary at 6761 Dempster St., Morton Grove, IL 60053 in the village’s Sawmill Station plaza. Morton Grove will deepen MedMen’s Illinois presence as part of a signicant investment along Dempster Street. “We are grateful to the community at Morton Grove for placing their trust in MedMen,” said Tom Lynch, Chairman and Chief Executive Ocer of MedMen. “Our stores provide top-level service to both medical and recreational cannabis users, and we are excited to be able to serve our Illinois customers at this new location. MedMen is the most recognizable brand in cannabis, and we are condent this store will be a continuation of our success in Illinois. The location not only adds to our valuable asset portfolio, but also demonstrates management’s ability to execute our strategic growth plan.” About MedMen MedMen is a premier American cannabis retailer with an operational footprint in California, Nevada, Illinois, Arizona, Massachusetts and Florida. MedMen oers a robust selection of high-quality products, including MedMen- 1 owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up.
    [Show full text]
  • Medmen Announces Growth Plan Update
    NEWS RELEASE MedMen Announces Growth Plan Update 6/29/2021 LOS ANGELES--(BUSINESS WIRE)-- MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), is pleased to provide updates regarding its operations in Arizona, West Hollywood, CA and Oak Park, IL as it continues to achieve key milestones in its growth plan. Arizona: Following the passage and expeditious roll-out of adult-use sales in Arizona, the Company will reclassify its Arizona operations from discontinued to continuing operations in the fourth quarter of 2021 where it continues to build on its success at its Scottsdale, AZ retail location and in its wholesale operations through its Mesa, AZ cultivation and manufacturing facility. West Hollywood, CA: On June 1, 2021, after several years of work in partnership with the City of West Hollywood, the West Hollywood Business License Commission voted unanimously to approve MedMen’s Legacy Medical Business application, which will enable the Company to continue operating its agship location in West Hollywood both as a medical and adult-use retailer. The Company anticipates receiving its new license in the coming weeks. Oak Park, IL: At its Oak Park, IL location, one of the Company’s highest revenue dispensaries, the Company will open its expanded retail store in July 2021, which includes an additional 3,332 square feet, bringing the location to a total of 7,732 square feet, and a highly visible street facing storefront. “With the signicant progress we are making turning the MedMen story from one of turnaround to one of growth, we anticipate sharing more consistent updates on the business trajectory going forward,” said Tom Lynch, Chairman and Chief Executive Ocer of MedMen.
    [Show full text]
  • Medmen Enterprises, Inc. Quarterly Report on Form 10­Q for the Quarterly Period Ended September 26, 2020
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________________ FORM 10­Q _______________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 26, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ MEDMEN ENTERPRISES INC. (Exact name of registrant as specified in its charter) _______________________ British Columbia 98­1431779 (State or other jurisdiction of (I.R.S. employer incorporation or organization) identification no.) 10115 Jefferson Boulevard Culver City, California 90232 (Address of principal executive offices) (zip code) (424) 330­2082 (Registrant’s telephone number, including area code) _______________________ Securities registered pursuant to Section 12(b) of the Act: None. _______________________ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S­T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non­accelerated filer, a smaller reporting company, or an emerging growth company.
    [Show full text]
  • Medmen Opens First Miami Location in South Beach
    NEWS RELEASE MedMen Opens First Miami Location in South Beach 4/29/2021 The Location Will Oer MedMen’s Signature Brands and MedMen Buds Loyalty Program to Miami’s Medical Marijuana Patients LOS ANGELES--(BUSINESS WIRE)-- (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today announced the opening of its rst Miami location in the heart of South Beach on Collins Avenue, just two blocks from the historic Art Deco District and lively beach. MedMen South Beach will welcome Florida’s medical marijuana card holders with a robust oering including classic and exotic ower strains, pre rolls, vaporizers and edibles from leading brands such as MedMen’s signature house brands MedMen and Luxlyte, with Mary’s Medicinals, Dixie, and Mindset Vaporizers launching in the coming months. Cannabis patients can nd a team of knowledgeable associates to provide expert guidance and recommendations for each patient’s unique needs. In-store or online, patients can opt-in to MedMen Buds national loyalty program to receive exclusive access to sales and discounts. Members earn points for every purchase which can be redeemed for a variety of rewards. “We are thrilled to become a part of the Miami community with the opening of our MedMen South Beach dispensary,” said Tom Lynch, Chairman and Chief Executive Ocer of MedMen. “MedMen has a strong reputation for quality service to the medical marijuana community, and our highly educated associates make shopping with us a breeze, regardless of your experience with cannabis. We remain committed to the highest standards of quality, inclusivity and customer service, and our Miami location deepens our commitment to Florida and the people there.” “As Senate District 38 continues to grow at a rapid rate, it is important that the people of our community with 1 signicant illnesses, such as PTSD and chronic pain, have access to medical cannabis,” said State Senator Jason Pizzo.
    [Show full text]
  • Lavish Parties, Greedy Pols and Panic Rooms: How the 'Apple of Pot
    AD INVESTIGATION Lavish Parties, Greedy Pols and Panic Rooms: How the ‘Apple of Pot’ Collapsed MedMen was the country’s hottest pot startup—until it flamed out. Its fall has exposed the gap between “green rush” hype and the realities of a troubled industry. Illustration by Julien Pacaud B y BEN SCHRECKINGER a n d M O N A Z H A N G 05/24/2020 07:03 AM EDT Ben Schreckinger is a national correspondent for POLITICO. Mona Zhang is the states cannabis policy reporter for POLITICO Pro. he warm California sun shone down on Adam Bierman as he stepped T up to the ceremonial ribbon strung across the entrance of his latest triumph: a new store on Abbot Kinney Boulevard in Venice, the hottest retail strip west of the Mississippi. Bierman stood facing a pack of clamoring photographers. Behind him, inside the shop, were besuited politicians, including Congressman Ted Lieu, who had come out to show their support. The actress Rosario Dawson, now known in Washington as Cory Booker’s girlfriend, was also on hand, recording the scene on her iPhone. Bierman, who styled himself the Steve Jobs of the “green rush” into legal weed, sported a red hoodie emblazoned with a white pot leaf. It was early June, 2018, barely a week since MedMen, the cannabis business he led, had gone public on a Canadian stock exchange, boasting an implied valuation of $1.6 billion. “We want the world to walk in and see what the future looks like,” he said. “And the future is right here on Abbot Kinney.” At the time, MedMen indeed looked to become the Apple of pot, the first mainstream, nationwide consumer brand for the product that drove so many Americans to ingest and invest.
    [Show full text]
  • Medmen Annual Report 2019 Letter from Our Founders
    Annual Report 2019 MedMen Annual Report 2019 Letter from our Founders Dear Fellow Shareholders: With the close of fiscal 2019, we are approaching who share their in-store and digital experiences Maintain Continuity with Change “The key to our success has been the 10-year anniversary of the simple idea from with family and friends, unlocking the power of In a rapidly changing environment, the key to our which MedMen was originally founded: that word-of-mouth. success has been our ability to balance continuity society becomes safer, healthier and happier as with change – to continue to provide the highest- our ability to balance continuity it is introduced to the benefits of legal, regulated Our success is also largely the result of our employees quality retail experience and stay true to our cannabis. As the leading cannabis retailer in the U.S., whose continued commitment to advancing cannabis mission and values – while at the same time meet with change.” MedMen has helped lay the groundwork for our education has made MedMen the company we are evolving consumer demands, push the boundaries industry for almost a decade, introducing millions today. We ended the year with over 1,300 employees, of agriculture and drive the way for much needed of first-time customers to the life-changing benefits a far cry from the early days when we had less than 30 regulatory reform in our industry. We look at of cannabis. Naturally, we have evolved through the people working at our company. cannabis retail similar to other disruptive industries, many stages in the life of a growing business and, such as ride sharing, music streaming or vacation now, having completed our first year as a public There is no question that we have become a rentals, where leading companies have been able company, we can reflect on where we stand and cannabis retail institution.
    [Show full text]
  • August 17, 2021
    & AUGUST 17, 2021 CSE: MMEN | OTC: MMNFF NASDAQ: TLRY | TSX: TLRY MEDMEN DISCLAIMER IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING NON-GAAP FINANCIAL AND PERFORMANCE MEASURES The information contained in this presentation has been prepared by MedMen Enterprises Inc. (“MedMen” or “the Company”) and contains In addition to providing financial measurements based on GAAP, the Company provides additional financial metrics that are not prepared in information pertaining to the business, operations, assets and prospects of the Company. The information contained in this presentation (a) is accordance with GAAP. Management uses non-GAAP financial measures, in addition to GAAP financial measures, to understand and provided as at the date hereof, unless otherwise stated, and is subject to change without notice, (b) does not purport to contain all the compare operating results across accounting periods, for financial and operational decision-making, for planning and forecasting purposes information that may be necessary or desirable to fully and accurately evaluate an investment in the Company, and (c) is not to be considered and to evaluate the Company’s financial performance. Examples of such non-GAAP financial measures include Retail Adjusted EBITDA and as a recommendation by the Company that any person make an investment in MedMen. Other than as may be required by applicable laws, Corporate SG&A. the Company is under no obligation to update any information included in this presentation. An investment in the securities of the Company is Management believes that these non-GAAP financial measures reflect the Company’s ongoing business in a manner that allows for speculative and involves a number of risks.
    [Show full text]
  • Corporate Presentation
    CSE: MMEN | OTC: MMNFF Corporate Presentation October 2020 1 Disclaimer IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING The information contained in this presentation has been prepared by MedMen Enterprises Inc. (“MedMen” or “the Company”) and contains information pertaining to the business, operations, assets and prospects of the Company. The information contained in this presentation (a) is provided as at the date hereof, unless otherwise stated, and is subject to change without notice, (b) does not purport to contain all the information that may be necessary or desirable to fully and accurately evaluate an investment in the Company, and (c) is not to be considered as a recommendation by the Company that any person make an investment in MedMen. Other than as may be required by applicable laws, the Company is under no obligation to update any information included in this presentation. An investment in the securities of the Company is speculative and involves a number of risks. Other than as may be authorized by the Company upon request, this presentation may not be reproduced, in whole or in part, in any form or forwarded or further distributed to any other person. Any forwarding, distribution or reproduction of this presentation in whole or in part is unauthorized. The Company takes no responsibility for, and provides no assurance as to the reliability of, any information that others may give readers of this presentation. FORWARD-LOOKING INFORMATION AND RISK ACKNOWLEDGEMENTS This document contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
    [Show full text]